Nucor Upgraded by UBS to Buy with $190 Target
UBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
VIX and daily volatility offer complementary views of risk. This overview explains how to interpret both for better timing and sizing.
21,595 articlesUBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
Robinhood's stock dropped about 6% after the company unveiled a $1.5 billion buyback. Yet investors remain skeptical ...
A leading AI company hints at a monumental goal: $9 trillion in market value. We explore what that could mean for inv...
Morgan Stanley expands into crypto trading on its E*TRADE platform, offering a lower-cost option for millions of reta...
A surprising move in the stock market drew attention to Super Micro Computer. This article breaks down the forces beh...
AI stocks soared for years, then faced a rigorous test as valuations and demand shifted. This article breaks down wha...
Apple launched the MacBook Neo at a budget price, signaling a potential breakthrough for Mac demand. This article bre...
A hypothetical $1,000 XRP bet on election night would have endured wild swings and sharp turns. Here’s the latest rea...
Sandisk has surged as AI infrastructure gains grab headlines. But can the rally last? This article lays out 3-year sc...
The (PPL) 2026 earnings call offers clues on dividend stability, capital plans, and regulatory risk. This guide trans...
Investors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Ferrari delivered a quarter that topped estimates, yet the stock moved lower. This piece deciphers what drove the bea...